A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls

Drug Abuse Prevention Clinical Trial

Official title:

A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01813123
• Other study ID #: AAAJ3409
• Secondary ID: R01DA031782
• Status: Completed
• Phase: N/A
• Start date: March 2013
• Est. completion date: January 30, 2019

Study information

• Verified date: June 2019
• Source: Columbia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is designed to develop and test a gender-specific, web-based drug abuse prevention program. Study participants will be adolescent girls aged 13 and 14 years who will complete all measures online. Randomly assigned girls will also interact online with a skills-based program and subsequent annual booster sessions.

The study's primary hypothesis is that rates of 30-day alcohol and drug use will be lower among girls assigned to receive the intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 788
• Est. completion date: January 30, 2019
• Est. primary completion date: July 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 13 Years to 14 Years

Eligibility

Inclusion Criteria:

• resident of USA

• speaks English

• have private computer with Internet

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Drug Abuse Prevention
• Substance-Related Disorders

Intervention

Behavioral:
• RealTeen
A web-based, gender-specific program intended improve girls' cognitive and behavioral skills. Each of the 9 sessions requires approximately 20 minutes. After initial intervention, girls will receive two annual booster sessions (i.e., a 20-minute review of previously learned material indexed to new age).

Locations

Country	Name	City	State
United States	Columbia University School of Social Work	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Columbia University	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	30-day alcohol and drug use	Measures will ask girls to report, for the past 30 days, the number of: drinks of alcohol consumed, cigarettes smoked, puffs of marijuana, and times they consumed four or more drinks within 2 hours. Girls will also report past 30-day use of: inhalants, ecstasy, club drugs, prescription drugs for recreational use, heroin, and hallucinogens.	Up to 3 years